← Back to headlines
Eli Lilly Developing Diverse Weight Loss Drug Portfolio
Eli Lilly is reportedly expanding its research and development efforts to create a variety of weight loss drugs tailored to different patient needs and conditions.
15 Aug, 18:20 — 15 Aug, 18:20
Sources
Showing 1 of 1 sources
